Evidence map›Paper›PMID 35327355›Full record

ArticleBiomedicines2022

Research into Morphofunctional Characteristics of Erythrocytes in COVID-19 Patients.

Victor Revin, Larisa Balykova, Sergey Pinyaev, Ilya Syusin, Olga Radaeva, Nadezhda Revina, Yuliya Kostina, Evgeniy Kozlov, Vera Inchina, Igor Nikitin and 2 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomedicines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Victor RevinFederal State Budgetary Educational Institution of Higher Education, Ogarev Mordovia State University, 430005 Saransk, Russia.ORCID 0000-0001-6542-2667
Larisa BalykovaFederal State Budgetary Educational Institution of Higher Education, Ogarev Mordovia State University, 430005 Saransk, Russia.
Sergey PinyaevFederal State Budgetary Educational Institution of Higher Education, Ogarev Mordovia State University, 430005 Saransk, Russia.ORCID 0000-0002-2347-5020
Ilya SyusinFederal State Budgetary Educational Institution of Higher Education, Ogarev Mordovia State University, 430005 Saransk, Russia.ORCID 0000-0002-4993-6040
Olga RadaevaFederal State Budgetary Educational Institution of Higher Education, Ogarev Mordovia State University, 430005 Saransk, Russia.
Nadezhda RevinaFederal State Budgetary Educational Institution of Higher Education, Ogarev Mordovia State University, 430005 Saransk, Russia.
Yuliya KostinaFederal State Budgetary Educational Institution of Higher Education, Ogarev Mordovia State University, 430005 Saransk, Russia.
Evgeniy KozlovFederal State Budgetary Educational Institution of Higher Education, Ogarev Mordovia State University, 430005 Saransk, Russia.ORCID 0000-0001-8373-6109
Vera InchinaFederal State Budgetary Educational Institution of Higher Education, Ogarev Mordovia State University, 430005 Saransk, Russia.
Igor NikitinFederal State Autonomous Institution, Treatment and Rehabilitation Center of the Ministry of Health of the Russian Federation, 125367 Moscow, Russia.
Alexandr SalikovState Budgetary Institution of Healthcare, City Clinical Hospital after V.M. Buyanov of the Moscow Department of Health, 115516 Moscow, Russia.
Ilya FedorovState Budgetary Institution of Healthcare, City Clinical Hospital after V.M. Buyanov of the Moscow Department of Health, 115516 Moscow, Russia.
National Research Mordovia State University · RUMoscow City Clinical Hospital after V.M. Buyanov · RUMinistry of Health of the Russian Federation · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this paper, the erythrocytes of healthy donors and people with a confirmed diagnosis of COVID-19 were tested by Raman spectroscopy and laser interference microscopy. We argue that erythrocytes (red blood cells) in COVID-19 patients have an irregular shape, and their morphometric characteristics are impaired in comparison to healthy red blood cells. Raman spectroscopy also allows us to detect a decreased oxygen transport function of these erythrocytes. The combination of these methods-Raman spectroscopy and laser interference microscopy-is a highly effective method for the diagnosis of SARS-CoV-2.

Indexed as

COVID-19erythrocyteshemoglobinlaser interference microscopynovel coronavirus infectionRaman spectroscopy

Identifiers

PMID35327355
PMCPMC8945033
OpenAlexW4214556446

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.